These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27293907)

  • 21. Relationship between Zinc (Zn (2+) ) and Glutamate Receptors in the Processes Underlying Neurodegeneration.
    Pochwat B; Nowak G; Szewczyk B
    Neural Plast; 2015; 2015():591563. PubMed ID: 26106488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational investigation of Amyloid-β-induced location- and subunit-specific disturbances of NMDAR at hippocampal dendritic spine in Alzheimer's disease.
    Liang J; Kulasiri D; Samarasinghe S
    PLoS One; 2017; 12(8):e0182743. PubMed ID: 28837653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered distribution of mGlu2 receptors in β-amyloid-affected brain regions of Alzheimer cases and aged PS2APP mice.
    Richards G; Messer J; Faull RL; Stadler H; Wichmann J; Huguenin P; Bohrmann B; Mutel V
    Brain Res; 2010 Dec; 1363():180-90. PubMed ID: 20875805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular prion protein as a therapeutic target in Alzheimer's disease.
    Laurén J
    J Alzheimers Dis; 2014; 38(2):227-44. PubMed ID: 23948943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced Neurotoxicity.
    Dworzak J; Renvoisé B; Habchi J; Yates EV; Combadière C; Knowles TP; Dobson CM; Blackstone C; Paulsen O; Murphy PM
    PLoS One; 2015; 10(6):e0127730. PubMed ID: 26038823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid-beta decreases cell-surface AMPA receptors by increasing intracellular calcium and phosphorylation of GluR2.
    Liu SJ; Gasperini R; Foa L; Small DH
    J Alzheimers Dis; 2010; 21(2):655-66. PubMed ID: 20571220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurodegeneration. Potential Alzheimer's drug spurs protein recycling.
    Garber K
    Science; 2014 Apr; 344(6182):351. PubMed ID: 24763565
    [No Abstract]   [Full Text] [Related]  

  • 28. [Glutamate- and Gaba-mediated extrasynaptic diffuse signaling in the hippocampus].
    Sem'ianov AV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2004; 54(1):68-84. PubMed ID: 15069817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glutaminergic neurotransmission in Alzheimer's disease].
    Tooyama I; Yanagisawa D
    Nihon Rinsho; 2011 Oct; 69 Suppl 8():214-8. PubMed ID: 22787784
    [No Abstract]   [Full Text] [Related]  

  • 30. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.
    Almeida CG; Tampellini D; Takahashi RH; Greengard P; Lin MT; Snyder EM; Gouras GK
    Neurobiol Dis; 2005 Nov; 20(2):187-98. PubMed ID: 16242627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models.
    Shi C; Viccaro K; Lee HG; Shah K
    J Cell Sci; 2016 May; 129(9):1815-1830. PubMed ID: 28157684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal testing of hippocampal plasticity reveals the onset and maintenance of endogenous human Aß-induced synaptic dysfunction in individual freely behaving pre-plaque transgenic rats: rapid reversal by anti-Aß agents.
    Qi Y; Klyubin I; Harney SC; Hu N; Cullen WK; Grant MK; Steffen J; Wilson EN; Do Carmo S; Remy S; Fuhrmann M; Ashe KH; Cuello AC; Rowan MJ
    Acta Neuropathol Commun; 2014 Dec; 2():175. PubMed ID: 25540024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of beta-amyloid-containing polypeptides in hippocampus: evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin.
    Bahr BA; Abai B; Gall CM; Vanderklish PW; Hoffman KB; Lynch G
    Exp Neurol; 1994 Sep; 129(1):81-94. PubMed ID: 7925845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease.
    Canas PM; Simões AP; Rodrigues RJ; Cunha RA
    Neuropharmacology; 2014 Jan; 76 Pt A():51-6. PubMed ID: 24029236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
    Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
    Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
    Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
    J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Glutamate and Alzheimer's disease].
    Gazulla J; Cavero-Nagore M
    Rev Neurol; 2006 Apr 1-15; 42(7):427-32. PubMed ID: 16602060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered neurotransmission prior to cognitive decline in AβPP/PS1 mice, a model of Alzheimer's disease.
    Hascup KN; Hascup ER
    J Alzheimers Dis; 2015; 44(3):771-6. PubMed ID: 25374106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease.
    Parri HR; Hernandez CM; Dineley KT
    Biochem Pharmacol; 2011 Oct; 82(8):931-42. PubMed ID: 21763291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pinning the suspect to the crime in Alzheimer's.
    Finkel E
    Lancet; 1996 Nov; 348(9040):1506. PubMed ID: 8965592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.